TY - JOUR
T1 - Variations in antibiotic use and sepsis management in neonatal intensive care units
T2 - A european survey
AU - on behalf of European Antibiotics Study Group (EASG)
AU - Garrido, Felipe
AU - Allegaert, Karel
AU - Arribas, Cristina
AU - Villamor, Eduardo
AU - Raffaeli, Genny
AU - Paniagua, Miren
AU - Cavallaro, Giacomo
N1 - Funding Information:
Funding: This research was funded by NESTLE ESPAÑA S.A. (CIF A08005449) to Universidad de Navarra (IP131304001).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/9
Y1 - 2021/9
N2 - Management of neonatal sepsis and the use of antimicrobials have an important impact on morbidity and mortality. However, there is no recent background on which antibiotic regimens are used in different European neonatal intensive care units (NICUs). Our study aimed to describe the use of antibiotics and other aspects of early-and late-onset sepsis (EOS and LOS, respectively) management by European NICUs. We conducted an online survey among NICUs throughout Europe to collect information about antibiotic stewardship, antibiotic regimens, and general aspects of managing neonatal infections. NICUs from up to 38 European countries responded, with 271 valid responses. Most units had written clinical guidelines for EOS (92.2%) and LOS (81.1%) management. For EOS, ampicillin, penicillin, gentamicin, and amikacin were the most commonly used antibiotics. Analysis of the combinations of EOS regimens showed that the most frequently used was ampicillin plus gentamicin (54.6%). For LOS, the most frequently used antibiotics were vancomycin (52.4%), gentamicin (33.9%), cefotaxime (28%), and meropenem (15.5%). Other aspects of the general management of sepsis have also been analyzed. The management of neonatal sepsis in European NICUs is diverse. There was high self-reported adherence to the local clinical guidelines. There was homogeneity in the combination of antibiotics in EOS but less in LOS.
AB - Management of neonatal sepsis and the use of antimicrobials have an important impact on morbidity and mortality. However, there is no recent background on which antibiotic regimens are used in different European neonatal intensive care units (NICUs). Our study aimed to describe the use of antibiotics and other aspects of early-and late-onset sepsis (EOS and LOS, respectively) management by European NICUs. We conducted an online survey among NICUs throughout Europe to collect information about antibiotic stewardship, antibiotic regimens, and general aspects of managing neonatal infections. NICUs from up to 38 European countries responded, with 271 valid responses. Most units had written clinical guidelines for EOS (92.2%) and LOS (81.1%) management. For EOS, ampicillin, penicillin, gentamicin, and amikacin were the most commonly used antibiotics. Analysis of the combinations of EOS regimens showed that the most frequently used was ampicillin plus gentamicin (54.6%). For LOS, the most frequently used antibiotics were vancomycin (52.4%), gentamicin (33.9%), cefotaxime (28%), and meropenem (15.5%). Other aspects of the general management of sepsis have also been analyzed. The management of neonatal sepsis in European NICUs is diverse. There was high self-reported adherence to the local clinical guidelines. There was homogeneity in the combination of antibiotics in EOS but less in LOS.
KW - Antibiotics
KW - Early-onset sepsis
KW - Late-onset sepsis
KW - Meningitis
KW - Neonatal intensive care unit
UR - http://www.scopus.com/inward/record.url?scp=85114259797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114259797&partnerID=8YFLogxK
U2 - 10.3390/antibiotics10091046
DO - 10.3390/antibiotics10091046
M3 - Article
AN - SCOPUS:85114259797
SN - 2079-6382
VL - 10
JO - Antibiotics
JF - Antibiotics
IS - 9
M1 - 1046
ER -